Second Global Report on Urban Health
The global report analyzes progress in urban health equity through the lens of the MDGs and the forthcoming SDGs. Comprehensive analysis of large multinational datasets provides the core of the analysis in up to 99 countries. The Urban Health Index methodology provides a baseline measure and spatial analysis of service coverage for universal health coverage. Partner contributions to the report deliver additional analysis with respect to access to key determinants of health in the urban environment, particularly those for which the evidence of solutions are the most scientifically compelling. This presentation provides an update of analysis to date.
The global report demonstrates that while considerable progress has been made in the achievement of the MDGs, progress has not been uniform. There continues to be a great need to build equity across the post-MDG agenda. Urban environments are venues of persisting health inequity as well as ideal venues of opportunity for advancing the post-MDG agenda. The final report will be available in late 2015.
Learning Areas:Administration, management, leadership
Advocacy for health and health education
Public health or related public policy
Public health or related research
Social and behavioral sciences
Formulate compelling evidence-based arguments describing the magnitude and persistence of urban health inequity in the world's cities. Identify a range of proven solutions and tools for decision makers at all levels in cities.
Keyword(s): Urban Health, Public Health Policy
Qualified on the content I am responsible for because: I am a technical officer with the World Health Organization developing tools for measuring urban health and conducting urban health research. I was previously at the Hewlett Foundation where I managed our sub-Saharan African programs on population and reproductive health research and capacity building.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.